A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims ...
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
